Interestingly, IPP accumulation is less efficient in non-transformed cells than tumor cells with a pharmacologically relevant concentration of ABP (45, 61), allowing the immunotherapy for cancer by activating γδ T cells with ABP such as ZOL. This evidence concerns the gene IPP and cancer.